- Home
- /
- Academics
- /
- Medical Laboratory Technology
- /
- Steps to Apply
- /
PRE-ADMISSION INFORMATION
APPLICATION INFORMATION
IN THIS SECTION
CONTACT INFORMATION
Monday – Friday
8:00 a.m. – 5:00 p.m.
NAVARRO COLLEGE-CORSICANA
Program Director (903) 875-7516
Health Professions Advisor
(972) 923-5121
REQUEST INFO
Please use the form below to get more information about Navarro College. A member of our Recruiting staff will be in touch with you shortly. We hope to assist you in any way that we can.
Steps to Apply to the Medical Laboratory Technology Program
STEP 1
|
|
PRE-ADMISSION TO MLT PROGRAM |
DETAILS |
Apply to Navarro |
Must apply for admission to Navarro College or be a current / former student at Navarro. |
College / University, High School or GED graduate |
Must provide transcripts from other colleges and universities or GED/High School diploma. |
Applications are accepted year round, with priority given to:
|
STEP 2
|
|
REQUIREMENT |
DETAILS |
Complete the MLT Program Application |
Submit an online MLT Program application with transcripts of completed courses. |
Hepatitis B Immunization series
|
A three (3) shot series should be started immediately if not already immunized. |
STEP 3
|
|
Begin gathering documentation required for admission. |
|
REQUIREMENT |
DETAILS |
State criminal background check |
Documentation of a clear background check is required by the clinical facilities. http://www.txdps.state.tx.us/. Cost (estimate): $3.45 for 1 credit. |
FBI background check |
Required prior to clinicals. Must schedule a fingerprint appointment. Cost: $50 |
Drug Screen |
All students will be required to submit to a random 10-panel drug screen. The time and date is arranged by the program director.All screening will be performed by a NC approved facility. Cost ranges $35-$60 |
Additional Drug Screening |
May be required by the Program Chair or clinical facility. |
Basic Life Support (BLS) |
Basic life support training is required by clinical sites. Cost of course is $40. |
Personal Health Insurance Policy |
Due to the possibility of exposure of infectious agents, students are strongly urged to carry a personal health insurance policy.Clinical facilities may require it. |
All students must provide proof of current immunizations as described by the Texas
Department of Health and the clinical site prior to clinicals. Proof of immunization
must be provided by the date specified by the instructor, or the student will be unable
to advance through the program.
REQUIRED IMMUNIZATIONS |
IMMUNIZATION DETAILS |
MMR (Measles, Mumps, Rubella) |
A series of two (2) vaccinations
|
Hepatitis B vaccine
|
A series of three (3) vaccinations.Students are required to show proof of up-to-date immunizations prior to clinicals.Students shall receive a complete series of Hepatitis vaccine prior to the start of direct patient care or show serologic confirmation of immunity to Hepatitis B virus. |
Tetanus/Diphtheria |
Current within the last 10 years |
Varicella (Chicken Pox) |
Completion of vaccination series (2 immunizations) or evidence of having had the disease (titer) |
Tuberculosis (TB) skin test |
TB skin test must remain current for the duration of the program. TB skin tests are valid for 12 months. |
Influenza |
Individual clinical sites may require influenza immunization |
Poliomyelitis |
Students enrolled in health-related courses are encouraged to ascertain that they are immune to poliomyelitis. |
Additional immunizations |
Individual clinical sites may require additional immunizations, or other additional information.Must provide required documentation for clinicals:
|
HEPATITIS B RISK INFORMATION
Specimens used in student labs and speciments encountered during clinicals may contain potentially infectious materials. Due to this, students are at risk of acquiring Hepatitis B virus (HBV) infection, and infection from other bloodborne pathogens. Prior to clinicals, students must be immunized for Hepatitis B virus or demonstrate immunization. The vaccination procedure includes three (3) intramuscular injections of Hepatitis B vaccine. Occasionally, the desired level of antibodies against Hepatitis B virus may not be acquired with the first series of vaccinations, and that additional vaccinations may be needed to achieve immunity. In some cases, the desired level of antibodies are not achieved even with repeated series of vaccines.
It is the student's responsibility to complete the series of three (3) injections as recommended.
Certain risks are involved in this vaccine, including:
a. hypersensitivity to components in the vaccine
b. soreness and redness at injection site
c. low grade fever with first 48 hours following vaccination
d. rarely: malaise, fatigue, headache, nausea, dizziness, myalgia, arthralgia, or
indurations at injection sight.